None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All women in the selected clusters, aged 30-49 years, married, with no previous history of cervical cancer, with an intact uterus
Exclusion criteria
Exclusion criteria: Clusters where a recent HPV based screening trial has been done History of cervical cancer/hysterectomy Pregnancy Women with abnormal inter-menstrual or post-menopausal bleeding Menstruation or within 12 weeks of delivery/abortion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| percent well managed (Completed a valid screening test (sample processed successfully to positive or negative result, including recollection of invalid samples) AND i) for HPV negative women, woman advised of negative result or ii) for HPV positive women, completed assessment and, if needed, treatment]Timepoint: 12 months (end of trial) | — |
Secondary
| Measure | Time frame |
|---|---|
| Representativeness of screened participants out of eligible womenTimepoint: 12 months (end of trial);Acceptability of HPV self samplingTimepoint: 12 months (end of trial);Cost effectiveness in terms of incremental costs per QALY gained, cost per case screened and treatedTimepoint: 12 months (end of trial) | — |
Countries
India
Contacts
Christian Medical College Vellore